Patents by Inventor Harry A. Puryear

Harry A. Puryear has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10117580
    Abstract: Radio frequency (RF) energy is transmitted through the application of a RF signal to an external RF energy interface, where the RF signal oscillates at a frequency in an energy transmission band. The transmitted RF energy is received at an implanted medical device, and energy derived from the received RF energy is stored in a direct current (DC) energy storage component of the device. A therapeutic output signal is generated from the stored energy and delivered by the implantable medical device to a patient through one or more electrodes. The therapeutic output signal is configurable to provide either one of RF stimulation therapy and RF ablation therapy, and comprises pulses of an RF signal oscillating at a frequency in a therapy band that is greater than the energy transmission band.
    Type: Grant
    Filed: October 6, 2017
    Date of Patent: November 6, 2018
    Assignee: SynerFuse, Inc.
    Inventors: Harry Puryear, Timothy J. Cox, Serafin Y. Samson, Nazmi Peyman, Omid Souresrafil, Gregory F. Molnar
  • Publication number: 20180280082
    Abstract: Systems and methods provide interface to a patient's autonomic nerves via an interior lumen wall of a blood vessel. Systems can include a probe having at least one electrode for receiving electrical signals from the interior of the lumen wall. The system can include processing components for extracting the signals from noise within the patient's body. Systems can include stimulation electrodes for providing stimulation and eliciting action potentials within the patient and destructive processes for destroying nervous function. The effect of nerve destruction on the propagation of action potentials can be effectively used as a feedback mechanism for determining the amount of nervous function destruction in the patient.
    Type: Application
    Filed: June 4, 2018
    Publication date: October 4, 2018
    Inventors: Harry A. Puryear, Jin Shimada
  • Publication number: 20180271593
    Abstract: The present invention is directed to bipolar ablation systems. A bipolar electrode system for ablation therapy is disclosed, including a pressure-sensitive conducting composite layer and a pair of electrodes in electrical conductive contact or communication with the pressure-sensitive conducting composite layer. Energy (e.g., ablation energy) is delivered via the pressure-sensitive conductive composition when sufficient pressure is applied to transform the pressure-sensitive conductive composite to an electrical conductor. An electrically insulative flexible layer, which may include a passageway for a fill material is also disclosed. In some embodiments, the systems can also be used for targeted delivery of compounds, such as drugs, using a bipolar electrode.
    Type: Application
    Filed: March 16, 2018
    Publication date: September 27, 2018
    Inventors: Saurav Paul, Harry A. Puryear, Riki Chou Thao, Hong Cao
  • Publication number: 20180221087
    Abstract: Systems and methods provide interface to a patient's autonomic nerves via an interior lumen wall of a blood vessel. Systems can include a probe having at least one electrode for receiving electrical signals from the interior of the lumen wall. The system can include processing components for extracting the signals from noise within the patient's body. Systems can include stimulation electrodes for providing stimulation and eliciting action potentials within the patient and destructive processes for destroying nervous function. The effect of nerve destruction on the propagation of action potentials can be effectively used as a feedback mechanism for determining the amount of nervous function destruction in the patient.
    Type: Application
    Filed: April 2, 2018
    Publication date: August 9, 2018
    Inventors: Harry A. Puryear, Jin Shimada
  • Patent number: 9999463
    Abstract: Systems and methods provide interface to a patient's autonomic nerves via an interior lumen wall of a blood vessel. Systems can include a probe having at least one electrode for receiving electrical signals from the interior of the lumen wall. The system can include processing components for extracting the signals from noise within the patient's body. Systems can include stimulation electrodes for providing stimulation and eliciting action potentials within the patient and destructive processes for destroying nervous function. The effect of nerve destruction on the propagation of action potentials can be effectively used as a feedback mechanism for determining the amount of nervous function destruction in the patient.
    Type: Grant
    Filed: April 10, 2015
    Date of Patent: June 19, 2018
    Assignee: NeuroMedic, Inc.
    Inventors: Harry A. Puryear, Jin Shimada
  • Patent number: 9949792
    Abstract: The present invention is directed to bipolar ablation systems. A bipolar electrode system for ablation therapy is disclosed, including a pressure-sensitive conducting composite layer and a pair of electrodes in electrical conductive contact or communication with the pressure-sensitive conducting composite layer. Energy (e.g., ablation energy) is delivered via the pressure-sensitive conductive composition when sufficient pressure is applied to transform the pressure-sensitive conductive composite to an electrical conductor. An electrically insulative flexible layer, which may include a passageway for a fill material is also disclosed. In some embodiments, the systems can also be used for targeted delivery of compounds, such as drugs, using a bipolar electrode.
    Type: Grant
    Filed: July 23, 2012
    Date of Patent: April 24, 2018
    Assignee: St. Jude Medical, Atrial Fibrillation Division, Inc.
    Inventors: Saurav Paul, Harry A. Puryear, Riki Thao, Hong Cao
  • Publication number: 20170360448
    Abstract: A method is provided for ablating a portion of the myocardium. The method includes inserting an occlusion catheter into a vessel on a heart, occluding the vessel using the occlusion catheter, inserting an ablation catheter into a chamber of the heart, positioning the ablation catheter against the myocardium, and ablating a portion of the myocardium while the vessel is occluded. The system includes an occlusion catheter having a catheter body including a tubular member having a distal portion and a bend located in the distal portion, a balloon located proximal of the bend and configured to contact an inner surface of the CS when positioned therewithin, a plurality of marker bands positioned on the catheter body, and a plurality of electrodes positioned on the catheter body. One or more electrodes or coils can be used as a reference for an electroanatomical system and can be disposed on the occlusion catheter.
    Type: Application
    Filed: June 27, 2017
    Publication date: December 21, 2017
    Inventors: James V. Kauphusman, Andre d'Avila, Vivek Reddy, William M. Sutton, Steven C. Christian, Harry A. Puryear
  • Publication number: 20170333710
    Abstract: An electrical ear nerve stimulation earpiece apparatus includes an earpiece body configured to fit on or in the ear. A first electrode is coupled to a surface of the earpiece configured to stimulate a cranial nerve, and a second electrode is coupled to a surface of the earpiece configured to stimulate a spinal nerve. Circuitry coupled to or in the earpiece is operable to provide an electrical signal to at least the first and second electrodes to treat a disorder affecting the nervous system by stimulating the spinal nerve and the cranial nerve.
    Type: Application
    Filed: April 21, 2017
    Publication date: November 23, 2017
    Inventors: Jin Shimada, Harry A. Puryear
  • Patent number: 9717501
    Abstract: A method is provided for ablating a portion of the myocardium. The method includes inserting an occlusion catheter into a vessel on a heart, occluding the vessel using the occlusion catheter, inserting an ablation catheter into a chamber of the heart, positioning the ablation catheter against the myocardium, and ablating a portion of the myocardium while the vessel is occluded. The system includes an occlusion catheter having a catheter body including a tubular member having a distal portion and a bend located in the distal portion, a balloon located proximal of the bend and configured to contact an inner surface of the CS when positioned therewithin, a plurality of marker bands positioned on the catheter body, and a plurality of electrodes positioned on the catheter body. One or more electrodes or coils can be used as a reference for an electroanatomical system and can be disposed on the occlusion catheter.
    Type: Grant
    Filed: May 21, 2010
    Date of Patent: August 1, 2017
    Assignee: St. Jude Medical, Atrial Fibrillation Division, Inc.
    Inventors: James V. Kauphusman, Andre d'Avila, Vivek Y. Reddy, William M. Sutton, Steven C. Christian, Harry A. Puryear
  • Patent number: 9675410
    Abstract: An electrode for use on a medical device is disclosed. The electrode may have a main body of electrically conductive material extending along an axis and may have a proximal end and a distal end. The electrode may also include a magnetic resonance imaging (MRI) tracking coil disposed in the body. The MRI tracking coil may comprise electrically insulated wire. A catheter including an electrode, as well as a method for determining the location of an electrode, are also disclosed.
    Type: Grant
    Filed: December 28, 2007
    Date of Patent: June 13, 2017
    Assignee: St. Jude Medical, Atrial Fibrillation Division, Inc.
    Inventors: Saurav Paul, Troy T. Tegg, Chou Thao, Harry Puryear
  • Patent number: 9616199
    Abstract: An irrigated catheter includes a catheter body having both proximal and distal irrigation passageways. A first fluid delivery tube feeds the proximal irrigation passageway and is fluidly isolated from the distal irrigation passageway, while a second fluid delivery tube feeds the distal irrigation passageway and is fluidly isolated from the proximal irrigation passageway. Typically, the first and second fluid delivery tubes will be unitary, at least through the catheter body. The overall shape of the first and second fluid delivery tubes, as well as their respective lumens, may vary as necessary for a particular application of the irrigated catheter. The system also includes an irrigation fluid source and at least one pump to deliver the irrigation fluid through the irrigation passageways. Typically, the pump will be a volume-driven pump, such as a rolling pump.
    Type: Grant
    Filed: December 31, 2009
    Date of Patent: April 11, 2017
    Assignee: St. Jude Medical, Atrial Fibrillation Division, Inc.
    Inventors: Huisun Wang, Dale E. Just, Harry A. Puryear
  • Patent number: 9610119
    Abstract: A method and system for assessing lesion formation in tissue is provided. The system includes an electronic control unit (ECU) configured to acquire magnitudes for a component of a complex impedance between an electrode and tissue, and the power applied to the tissue during lesion formation. The ECU is configured to calculate a value responsive to the complex impedance component and the power. The value is indicative of a predicted lesion depth, a likelihood the lesion has reached a predetermined depth, or a predicted tissue temperature. The method includes acquiring magnitudes for a component of a complex impedance between an electrode and tissue and the power applied during lesion formation. The method includes calculating a value responsive to the complex impedance component and the power, the value being indicative of a predicted lesion depth, a likelihood the lesion has reached a predetermined depth, and/or a predicted tissue temperature.
    Type: Grant
    Filed: November 22, 2013
    Date of Patent: April 4, 2017
    Assignee: St. Jude Medical, Atrial Fibrillation Division, Inc.
    Inventors: Jeffrey M. Fish, Israel A. Byrd, Lynn E. Clark, Jeremy D. Dando, Christopher J. Geurkink, Harry A. Puryear, Saurav Paul
  • Publication number: 20170035310
    Abstract: An intraluminal microneurography probe has a probe body configured to be introduced into an artery near an organ of a body without preventing the flow of blood through the artery. An expandable sense electrode and an expandable stimulation electrode are fixed to the probe body at one end of each electrode such that movement of the other end toward the fixed end causes the sense electrode to expand from the probe body toward a wall of the artery. A ground electrode is configured to couple to the body, and a plurality of electrical connections are operable to electrically couple the electrodes to electrical circuitry. The sense electrode is operable to measure sympathetic nerve activity in response to excitation of the stimulation electrode. A radio frequency ablation element is located between the expandable sense electrode and expandable stimulation electrode, and is operable to ablate nerves proximate to the artery.
    Type: Application
    Filed: October 21, 2016
    Publication date: February 9, 2017
    Inventors: Jin Shimada, Harry A. Puryear
  • Publication number: 20170027460
    Abstract: An intraluminal microneurography probe has a probe body that is configured to be introduced into an artery near an organ of a body without preventing the flow of blood through the artery. An expandable sense electrode and an expandable stimulation electrode are fixed to the probe body at one end of each electrode such that movement of the other end toward the fixed end causes the sense electrode to expand from the probe body toward a wall of the artery. A ground electrode is configured to couple to the body, and a plurality of electrical connections are operable to electrically couple the electrodes to electrical circuitry. The sense electrode is operable to measure sympathetic nerve activity in response to excitation of the stimulation electrode. An ablation element is located between the expandable sense electrode and expandable stimulation electrode, and is operable to ablate nerves proximate to the artery.
    Type: Application
    Filed: July 7, 2016
    Publication date: February 2, 2017
    Inventors: Jin Shimada, Harry A. Puryear, Gregory G. Brucker
  • Patent number: 9549777
    Abstract: Embodiments of the present invention provide an irrigated catheter having irrigation fluid directed at target areas where coagulation is more likely to occur so as to minimize blood coagulation and the associated problems. In one embodiment, an irrigated ablation electrode assembly for use with an irrigated catheter device comprises a proximal member having at least one passageway for a fluid with an outlet disposed at an external surface of the proximal member; and a distal member connected with the proximal member and having an external surface. The distal member includes an electrode. The external surface of the proximal member and the external surface of the distal member meet at an intersection. The at least one passageway of the proximal member is configured to direct a fluid flow through the outlet toward a region adjacent the intersection.
    Type: Grant
    Filed: August 7, 2015
    Date of Patent: January 24, 2017
    Assignee: St. Jude Medical, Atrial Fibrillation Division, Inc.
    Inventors: Huisun Wang, Jeremy D. Dando, Harry A. Puryear
  • Publication number: 20160256682
    Abstract: Catheter systems include direction-sensitive, multi-polar tip electrode assemblies for electroporation-mediated therapy, electroporation-induced primary necrosis therapy and electric field-induced apoptosis therapy, including configurations for producing narrow, linear lesions as well as distributed, wide area lesions. A monitoring system for electroporation therapy includes a mechanism for delivering electrochromic dyes to a tissue site as well as a fiber optic arrangement to optically monitor the progress of the therapy as well as to confirm success post-therapy. A fiber optic temperature sensing electrode catheter includes a tip electrode having a cavity whose inner surface is impregnated or coated with thermochromic/thermotropic material that changes color with changes in temperature. An optic fiber/detector arrangement monitors the thermochromic or thermotropic materials, acquiring a light signal and generating an output signal indicative of the spectrum of the light signal.
    Type: Application
    Filed: March 9, 2016
    Publication date: September 8, 2016
    Inventors: Saurav Paul, Troy T. Tegg, Israel A. Byrd, Riki Thao, Harry A. Puryear, Linda Nemec, John M. Berns
  • Patent number: 9289606
    Abstract: Catheter systems include direction-sensitive, multi-polar tip electrode assemblies for electroporation-mediated therapy, electroporation-induced primary necrosis therapy and electric field-induced apoptosis therapy, including configurations for producing narrow, linear lesions as well as distributed, wide area lesions. A monitoring system for electroporation therapy includes a mechanism for delivering electrochromic dyes to a tissue site as well as a fiber optic arrangement to optically monitor the progress of the therapy as well as to confirm success post-therapy. A fiber optic temperature sensing electrode catheter includes a tip electrode having a cavity whose inner surface is impregnated or coated with thermochromic/thermotropic material that changes color with changes in temperature. An optic fiber/detector arrangement monitors the thermochromic or thermotropic materials, acquiring a light signal and generating an output signal indicative of the spectrum of the light signal.
    Type: Grant
    Filed: September 2, 2010
    Date of Patent: March 22, 2016
    Assignee: St. Jude Medical, Atrial Fibrillation Division, Inc.
    Inventors: Saurav Paul, Troy T. Tegg, Israel A. Byrd, Riki Thao, Harry A. Puryear, Linda Nemec, John M. Berns
  • Publication number: 20160030110
    Abstract: Embodiments of the present invention provide an irrigated catheter having irrigation fluid directed at target areas where coagulation is more likely to occur so as to minimize blood coagulation and the associated problems. In one embodiment, an irrigated ablation electrode assembly for use with an irrigated catheter device comprises a proximal member having at least one passageway for a fluid with an outlet disposed at an external surface of the proximal member; and a distal member connected with the proximal member and having an external surface. The distal member includes an electrode. The external surface of the proximal member and the external surface of the distal member meet at an intersection. The at least one passageway of the proximal member is configured to direct a fluid flow through the outlet toward a region adjacent the intersection.
    Type: Application
    Filed: August 7, 2015
    Publication date: February 4, 2016
    Inventors: Huisun S. Wang, Jeremy D. Dando, Harry A. Puryear
  • Publication number: 20150289931
    Abstract: Systems and methods provide interface to a patient's autonomic nerves via an interior lumen wall of a blood vessel. Systems can include a probe having at least one electrode for receiving electrical signals from the interior of the lumen wall. The system can include processing components for extracting the signals from noise within the patient's body. Systems can include stimulation electrodes for providing stimulation and eliciting action potentials within the patient and destructive processes for destroying nervous function. The effect of nerve destruction on the propagation of action potentials can be effectively used as a feedback mechanism for determining the amount of nervous function destruction in the patient.
    Type: Application
    Filed: April 10, 2015
    Publication date: October 15, 2015
    Inventors: Harry A. Puryear, Jin Shimada
  • Patent number: 9095349
    Abstract: A method and system for determining a likelihood of barotrauma occurring in tissue during formation of a lesion therein is provided. The system includes an electronic control unit (ECU). The ECU is configured to acquire at least one value of at least one component of a complex impedance between an electrode and the tissue. The ECU is configured to calculate an index responsive to the at least one value of the at least one complex impedance component. The index is indicative of a likelihood of barotrauma occurring in the tissue. The method comprises acquiring at least one value of at least one component of a complex impedance between an electrode and the tissue. The method comprises calculating an index responsive to the at least one value of the at least one complex impedance component. The calculated index is indicative of a likelihood of barotrauma occurring in the tissue.
    Type: Grant
    Filed: December 10, 2010
    Date of Patent: August 4, 2015
    Assignee: St. Jude Medical, Atrial Fibrillation Division, Inc.
    Inventors: Jeffrey M. Fish, Israel A. Byrd, Lynn Gilmour, Jeremy D. Dando, Christopher J. Geurkink, Rohan Lathia, Harry A. Puryear, Valtino X. Afonso, Saurav Paul